Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009–13. Issue 9 (September 2015)

• Record Type: Journal Article
• Authors: Fowlkes, Ashley; Steffens, Andrea; Temte, Jon; Lonardo, Steve Di; McHugh, Lisa; Martin, Karen; Rubino, Heather; Feist, Michelle; Davis, Carol; Selzer, Christine; Lojo, Jose; Oni, Oluwakemi; Kurkjian, Katie; Thomas, Ann; Boulton, Rachelle; Bryan, Nicole; Lynfield, Ruth; Biggerstaff, Matthew; Finelli, Lyn; Influenza Incidence Surveillance Project Working Group
• Is Part Of: Lancet. Volume 3:Issue 9(2015)
• Page Start: 709
• Page End: 718
• Publication Date: 2015-09
• Subjects: Respiratory organs -- Diseases -- Periodicals; 616.2005
• DOI: 10.1016/S2213-2600(15)00278-7
• Languages: English
• ISSNs: 2213-2600

Abstract

<abstract abstract-type="author" id="ceab10"> <title id="cestitle10">Summary</title> <sec> <title id="cestitle20">Background</title> <p id="spara120">Since the introduction of pandemic influenza A (H1N1) to the USA in 2009, the Influenza Incidence Surveillance Project has monitored the burden of influenza in the outpatient setting through population-based surveillance.</p> </sec> <sec> <title id="cestitle30">Methods</title> <p id="spara130">From Oct 1, 2009, to July 31, 2013, outpatient clinics representing 13 health jurisdictions in the USA reported counts of influenza-like illness (fever including cough or sore throat) and all patient visits by age. During four years, staff at 104 unique clinics (range 35–64 per year) with a combined median population of 368 559 (IQR 352 595–428 286) attended 35 663 patients with influenza-like illness and collected 13 925 respiratory specimens. Clinical data and a respiratory specimen for influenza testing by RT-PCR were collected from the first ten patients presenting with influenza-like illness each week. We calculated the incidence of visits for influenza-like illness using the size of the patient population, and the incidence attributable to influenza was extrapolated from the proportion of patients with positive tests each week.</p> </sec> <sec> <title id="cestitle40">Findings</title> <p id="spara140">The site-median peak percentage of specimens positive for influenza ranged from 58·3% to 77·8%. Children aged 2 to 17 years had the highest incidence of influenza-associated visits (range 4·2–28·0 per 1000 people by year), and adults older than 65 years had the lowest (range 0·5–3·5 per 1000 population). Influenza A H3N2, pandemic H1N1, and influenza B equally co-circulated in the first post-pandemic season, whereas H3N2 predominated for the next two seasons. Of patients for whom data was available, influenza vaccination was reported in 3289 (28·7%) of 11 459 patients with influenza-like illness, and antivirals were prescribed to 1644 (13·8%) of 11 953 patients.</p> </sec> <sec> <title id="cestitle50">Interpretation</title> <p id="spara150">Influenza incidence varied with age groups and by season after the pandemic of 2009 influenza A H1N1. High levels of influenza virus circulation, especially in young children, emphasise the need for additional efforts to increase the uptake of influenza vaccines and antivirals.</p> </sec> <sec> <title id="cestitle60">Funding</title> <p id="spara160">US Centers for Disease Control and Prevention.</p> </sec> </abstract>